Results 191 to 200 of about 40,684 (247)

Extraction of Sulfachloropyridazine from Food Samples Using Cellulose: Application of Central Composite Design Approach

open access: yesAnalytical Science Advances, Volume 7, Issue 1, June 2026.
Functionalized cellulose–ATPE for sulfachloropyridazine extraction. ABSTRACT Sulfonamide antibiotics are among the most widely used veterinary drugs in livestock and often end up contaminating milk, which is subsequently consumed by humans. To mitigate this health hazard, cellulose and its functionalized derivatives were investigated for their ability ...
Mbuyelo Shikweni   +4 more
wiley   +1 more source

Possible Factor Xa Resistance in a Patient Who Failed Apixaban and Rivaroxaban. [PDF]

open access: yesClin Case Rep
Ali O   +5 more
europepmc   +1 more source

Beyond CO2: Incorporating Bicarbonate, Dynamic Carbon Speciation, and Stoichiometric Plasticity Into Algal Growth Models

open access: yesBiotechnology and Bioengineering, Volume 123, Issue 6, Page 1491-1502, June 2026.
ABSTRACT The design of biological carbon capture systems to uptake carbon dioxide by photoautotrophic cultivation of algae has been proposed to mitigate atmospheric carbon emissions. Multiple models to predict algal growth as a function of nutrients have been proposed, but few have delved into the complex dynamic reactions of algal growth as influenced
Elizabeth Flanagan   +2 more
wiley   +1 more source

Variability in ACT Response to Standard UFH Bolus During PCI: A Prospective Study on Determinants of Subtherapeutic Anticoagulation

open access: yesCatheterization and Cardiovascular Interventions, Volume 107, Issue 7, Page 2293-2303, June 1, 2026.
ABSTRACT Background Unfractionated heparin (UFH) remains the standard anticoagulant during percutaneous coronary intervention (PCI), with guidelines recommending a target activated clotting time (ACT) of ≥250 s. However, despite receiving a standardized bolus dose, many patients fail to achieve this target.
Manh Cuong Vu   +9 more
wiley   +1 more source

A Prothrombotic Shift: Cerebral Venous Sinus Thrombosis in the Recovery Phase of Dengue Fever—A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Post‐dengue cerebral venous sinus thrombosis is an uncommon complication of dengue fever. It occurs due to a prothrombotic shift during the recovery or critical phase of dengue fever, presenting usually as a persistent headache. Prompt neuroimaging and anticoagulation are crucial to a favorable prognosis, even in the presence of hemorrhagic ...
Zain Ul Abedeen   +5 more
wiley   +1 more source

Acute Finger Ischemia Evaluated With Point‐Of‐Care‐Ultrasound and Diagnosed With Concurrent Polycythemia Vera, Antiphospholipid Syndrome, and Tobacco Use

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
We present a case of digital ischemia investigated and localized using point‐of‐care ultrasound (POCUS), in a patient that was subsrquently diagnosed with antiphospholipid syndrome and polycythemia vera concurrently, in the setting of active tobacco use. ABSTRACT In patients with undifferentiated extremity ischemia, point‐of‐care ultrasound (POCUS) can
Tristan Burgess   +2 more
wiley   +1 more source

Waste activated sludge high‐rate treatment of septage: Biodegradability studies and contact phase trials towards a cleaner environment

open access: yesThe Canadian Journal of Chemical Engineering, Volume 104, Issue 6, Page 2842-2861, June 2026.
Abstract The waste activated sludge high‐rate (WASHR) process, developed in our previous study, is used for septic wastewater treatment. This high‐rate contact stabilization pre‐treatment uses typical waste streams found in wastewater treatment plants to reduce a portion of the loadings on the main treatment trains.
Arman Shirali   +2 more
wiley   +1 more source

Efficacy of Factor Xa Inhibitors Versus Placebo in Thromboprophylaxis for Cancer-Associated Thromboembolism: A Systematic Review and Meta-analysis. [PDF]

open access: yesClin Appl Thromb Hemost
Kamil A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy